Guanosine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
-
![Guanosine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220811/f4f798af62b0433ca9a70a30cd4577f7.png "Guanosine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]")
Guanosine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
structure -
-
CAS No:
251647-55-9
-
Formula:
C47H60N7O10P
-
Chemical Name:
Guanosine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
-
Synonyms:
Guanosine,5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)-,3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite];Guanosine,5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)-,3′-[2-cyanoethyl bis(1-methylethyl)phosphoramidite];22: PN: US20030198965 PAGE: 20 claimed sequence;17: PN: US20030212017 PAGE: 20 claimed sequence;18: PN: US20030211606 PAGE: 20 claimed sequence;25: PN: WO03106645 PAGE: 73 claimed sequence;24: PN: US20040014699 PAGE: 21 claimed sequence;23: PN: US20040014051 PAGE: 23 claimed sequence;22: PN: US20040014050 PAGE: 21 claimed sequence;21: PN: US20040014049 PAGE: 21 claimed sequence;22: PN: US20040014048 PAGE: 21 claimed sequence;21: PN: US20040014047 PAGE: 21 claimed sequence;21: PN: US20040006030 PAGE: 23 claimed sequence;25: PN: US20040006029 PAGE: 23 claimed sequence;96: PN: US20040005707 PAGE: 21 claimed sequence;22: PN: US20040005570 PAGE: 21 claimed sequence;19: PN: US20040005569 PAGE: 22 claimed sequence;23: PN: US20040005565 PAGE: 17-22 claimed sequence;756870-24-3;1055896-90-6;1373846-67-3
- Categories:
-
CAS No:
Guanosine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] Basic Attributes
913.993961
913.99
Computed Properties
Molecular Weight:914.0
XLogP3:5.5
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:14
Rotatable Bond Count:23
Exact Mass:913.41392813
Monoisotopic Mass:913.41392813
Topological Polar Surface Area:189
Heavy Atom Count:65
Complexity:1550
Defined Atom Stereocenter Count:4
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
Adenosine, N-benzoyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxy-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
98796-53-3
-
Guanosine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxy-N-(2-methyl-1-oxopropyl)-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
93183-15-4
-
Uridine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxy-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
109389-30-2
-
Cytidine, N-benzoyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxy-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] Formula
102212-98-6
-
Thymidine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] Formula
98796-51-1
-
Uridine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-methyl-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] Formula
110764-79-9
-
25-Deoxyecdysone Structure
22005-50-1
-
compoundk Structure
160729-91-9
-
What is 7-[4-[4-(2-bromophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
203395-84-0
-
What is Moscatilin
108853-14-1
Guanosine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
SDSRequest for Quotation